Skip to main contentSkip to navigationSkip to search
14 Nov 2025
Regulatory press release

Strong position and positive EBITDA

Precise Biometrics Interim Report January – September 2025

Third quarter

  • Net sales totaled SEK 20.0 (22.8) million.
  • EBITDA totaled SEK 4.4 (6.8) million.
  • The operating profit/loss (EBIT) totaled SEK -0.6 (1.2) million
  • Earnings for the period totaled SEK -0.7 (1.4) million.
  • Earnings per share before and after dilution totaled SEK -0.01 (0.02)
  • Cash flow from operating activities totaled SEK 1.7 (3.3) million.
  • ARR (Annual Recurring Revenue) at the end of the period was SEK 18.4 (18.4) million.

Interim period January – September 

  • Net sales totaled SEK 60.8 (65.1) million
    • A change in revenue allocation in a renegotiated customer agreement results in higher revenue on an annual basis, but has a negative impact of SEK 1.8 million on net sales for the interim period
  • EBITDA totaled SEK 2.1 (9.9) million.
    • Adjusted for negative currency effects from operating items of SEK 2.5 million and a change in revenue allocation in a customer agreement of SEK 1.8 million, EBITDA amounts to SEK 6.4 million
  • The operating profit/loss (EBIT) totaled SEK -13.4 (-7.3) million
  • Earnings for the period totaled SEK -13.6 (-7.1) million.
  • Earnings per share before and after dilution totaled SEK -0.17 (-0.09)
  • Cash flow from operating activities totaled SEK 5.1 (4.3) million.
  • ARR (Annual Recurring Revenue) at the end of the period was SEK 18.4 (18.4) million.

Significant events during the quarter

Significant events after the end of the interim period

Presentation and live Q&A
Precise has published a video interview with CEO Joakim Nydemark in connection with this report. The video is available on the Investor Relations page: precisebiometrics.com/investors/
The company also invites you to a live Q&A session Friday, Nov 14, 2025, at 13:00 CET. More information and a registration link to the Q&A session may be found on the Investor Relations page: precisebiometrics.com/investors/.

CEO Joakim Nydemark comments

"We stand strong with a positive EBITDA, a stable cost base, and an offering that is more relevant than ever. Demand for our solutions is increasing across several of our key segments, even though sales cycles are becoming longer in a continued cautious market environment. During the quarter, we won new mobile phone projects, saw the launch of devices featuring our software, and made important advances in both anti-spoof technology and palm recognition. We also accelerated the migration to our cloud-based platform within Digital Identity – an important shift that creates a more scalable and long-term profitable business. With a comprehensive product portfolio, strong partner networks, and a market moving toward higher security standards, I see solid conditions for growth going forward."